Primary infection with Chlamydia trachomatis L2c in a porcine model produced urogenital pathology similar as in humans and failed to induce protective immune responses against re-infection by Vanrompay, Daisy et al.
Primary infection with Chlamydia trachomatis L2c in a porcine model 
produced urogenital pathology similar as in humans and failed to 
induce protective immune responses against re-infection 
 
Evelien De Clercq1, Matthias Van Gils1, Katelijn Schautteet1, Bert Devriendt2, Koen 
Chiers3, Eric Cox2, Deborah Dean4* and Daisy Vanrompay1* 
 
1Department of Molecular Biotechnology, Faculty of Bioscience Engineering, Ghent 
University, Coupure Links 653, B-9000 Ghent, Belgium. 2Laboratory of 
Immunology, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 
B-9820 Merelbeke, Belgium. 3Department of Pathology, Bacteriology and Poultry 
Diseases, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, B-
9820 Merelbeke, Belgium. 4Center for Immunobiology and Vaccine Development, 
Children’s Hospital Oakland, Research Institute, Oakland, California, USA.  
*shared senior authorship 
 
 We evaluated the pathogenesis, pathology and immune response of a female 
genital tract infection with Chlamydia trachomatis L2c, the most recently discovered 
lymphogranuloma venereum strain, using a porcine model of sexually transmitted 
infection. Pigs were mock infected, infected once or infected and re-infected 
intravaginally, and samples were obtained for chlamydial culture, gross and 
microscopic pathology, and humoral and cell-mediated immunity. Intravaginal 
inoculation of pigs with this bacterium resulted in an infection that was confined to 
the urogenital tract, where inflammation and pathology were caused that resembled 
what is seen in human infection. Re-infection resulted in more severe gross pathology 
than primary infection, and chlamydial colonization of the urogenital tract was similar 
for primary infected and re-infected pigs. This indicates that primary infection failed 
to induce protective immune responses against re-infection. Indeed, the proliferative 
responses of mononuclear cells from blood and lymphoid tissues to C. trachomatis 
strain L2c were never statistically different among groups, suggesting that C. 
trachomatis-specific lymphocytes were not generated following infection or re-
infection. Nevertheless, antichlamydial antibodies were elicited in sera and vaginal 
secretions after primary infection and re-infection clearly demonstrating a secondary 
systemic and mucosal antibody response. The porcine model is relevant for evaluating 
immune and pathogenic responses for emerging and known C. trachomatis strains to 
advance drug and/or vaccine development in humans.  
 
 
 
